DrugPamphlet Egypt: Egyptian Drug Guide & Commentaries

1. Disclaimer The information provided in this commentary is intended for educational and professional reference only. It does not replace medical judgment, official product information, or regulatory guidance. Product availability, indications, and safety recommendations may vary by country and may have changed since the original source document. We do not guarantee the accuracy, currency or completeness of information regarding medications or medical products, and official sources should be verified before making any decisions. By using this blog, you agree to assume personal responsibility for relying on the information provided. 2. Summary Osipect® Syrup is a fixed-dose combination cough preparation containing an expectorant (guaifenesin), a β₂-adrenergic bronchodilator (terbutaline sulfate), a first-generation antihistamine (diphenhydramine HCl), and potassium citrate. Historically, it was used for symptomatic relief of productive...

1. Disclaimer The information provided in this report is intended solely for educational and professional reference purposes and is not a substitute for medical advice, diagnosis, or treatment. Clinical decisions must always be based on the official prescribing information approved by regulatory authorities and the judgment of qualified healthcare professionals. We do not guarantee the accuracy, currency or completeness of information regarding medications or medical products, and official sources should be verified before making any decisions. By using this blog, you agree to assume personal responsibility for relying on the information provided. ⚠️ Critical Contextual Note: The primary source document for BRONCHOPHANE® Syrup (EIPICO leaflet, revision June 2011) is significantly outdated and reflects older polypharmacy practices that are no longer aligned with modern international guidelines, particularly due to the inclusion of ephedrine. Thi...

1. Disclaimer The information provided in this document is intended solely for educational and professional reference purposes and does not constitute medical advice, diagnosis, or treatment. Clinical decisions must be based on the approved prescribing information issued by relevant regulatory authorities and the professional judgment of qualified healthcare providers. We do not guarantee the accuracy, currency or completeness of information regarding medications or medical products, and official sources should be verified before making any decisions. By using this blog, you agree to assume personal responsibility for relying on the information provided. 2. Summary EPIRANT® is a historical brand name for ranitidine hydrochloride, a histamine H₂-receptor antagonist formerly used to suppress gastric acid secretion in acid-related gastrointestinal disorders. Ranitidine products were globally withdrawn or suspended between 2019 and 2020...